STAT3 Signaling Contributes to Chemokine Production in E2-Induced Dermal Inflammation
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27219454 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Nicolas Ancona und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Rheumatology and Immunology, Medical University of South Carolina, Charleston, SC 29425, USA. Hauptthemen laut MEDLINE: Signal Transduction, STAT3 Transcription Factor, Estradiol, Chemokines. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS, NCATS NIH HHS, NIH HHS.
Abstract (Originalsprache)
Scleroderma (SSc) is characterized by dermal inflammation and fibrosis. Patients with SSc have elevated circulating levels of estradiol (E2) that contribute to dermal fibrosis. Using bulk RNA sequencing (RNA-seq), we investigated inflammatory pathways in E2 or ethanol (ETOH, vehicle)-treated human skin tissue for 48 h to identify differentially expressed genes (DEGs) and enriched pathways. Among the 90 DEGs responsive to E2 treatment, many were associated with enriched inflammatory pathways. Likewise, cytokine and chemokine activities were among the most significantly enriched molecular function terms. qPCR and protein analyses demonstrated increased cytokine and chemokine expression in primary dermal fibroblasts. CIBERSORTx deconvolution using a skin single-cell reference suggested an activated fibroblast transcriptional signature in E2-treated human skin tissue. In this tissue, E2-induced IL-6 and CXCL8 transcript levels were positively correlated. Pharmacologic STAT3 inhibition reduced E2-induced CXCL2, CXCL3, CXCL8, and CCL20 transcript levels in human skin tissue. In SSc dermal fibroblasts, anastrozole treatment significantly decreased CXCL3 and CXCL8 transcript levels. Together, these data suggest that E2 contributes, in part, to increased CXCL2, CXCL3, CXCL8, and CCL20 transcripts and that IL-6/STAT3 signaling may be important in this dermal inflammatory response.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Division of Rheumatology and Immunology, Medical University of South Carolina, Charleston, SC 29425, USA.
- Department of Pediatrics-Rheumatology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
- Department of Biological & Physical Sciences, South Carolina State University, Orangeburg, SC 29117, USA.
ORCID-Profile: Nicolas Ancona, Yucui Li, Ludivine Renaud, Kaelyn Kear, DeAnna Baker Frost
Förderung
- NIAMS NIH HHS
- NCATS NIH HHS
- NIH HHS
- National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health
- National Institutes of Health/National Center for Advancing Translational Sciences
Zitieren
APA
Ancona, N., Li, Y., Renaud, L., Fierkens, R., Kear, K., Pinckney, K., & Baker Frost, D. (2026). STAT3 Signaling Contributes to Chemokine Production in E2-Induced Dermal Inflammation. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27219454
Vancouver
Ancona N, Li Y, Renaud L, Fierkens R, Kear K, Pinckney K, et al. STAT3 Signaling Contributes to Chemokine Production in E2-Induced Dermal Inflammation. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27219454
BibTeX
@article{Ancona2026,
author = {Ancona, Nicolas and Li, Yucui and Renaud, Ludivine and Fierkens, Roselyn and Kear, Kaelyn and Pinckney, Kaitlyn and Baker Frost, DeAnna},
title = {STAT3 Signaling Contributes to Chemokine Production in E2-Induced Dermal Inflammation},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27219454}
}
EUVIMED